Alnylam Pharmaceuticals
ALNY
#637
Rank
S$43.45 B
Marketcap
$335.64
Share price
-0.02%
Change (1 day)
66.67%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company